- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02058121
An ACT Group Intervention for ED-patients
Randomised Controlled Trial With Acceptance and Commitment Therapy (ACT) for Patients With Eating Disorders - a Manualised Group Therapy to Enhance Body Acceptance
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study is an RCT in which the ACT-intervention is compared to treatment as usual. The trial started in 2010, and randomisation of patients continued until 2014, and follow-ups was completed in 2016.
According to analysis of power, a total of 120 patients needed to be included, 60 in each arm. Patients eligible for the interventions were invited to participate after their clinician reported them to the head investigator. The head investigator sent a letter to the patients with information on the study. The clinician then asked the patient if the letter had been read. If the patient wanted to participate, he/she was invited to an information and assessment meeting. The head investigator made sure that the patient understood the information, and what each study arm might mean for the patient when participating. Consent to participate was collected both verbally and in writing. At this meeting the patient received an envelope which contained the randomisation outcome. The patient then received information regarding the continued treatment according to which research arm he/she was to participate in.
The participants randomised to treatment as usual continued with the treatment as planned before enrolment.
Participants in the intervention arm started the group intervention consisting of 12 sessions over a period of three to four months. The intervention also included one individual meeting with the group-leaders before and one after the intervention. The intervention is a manualised application of the book "Lev med din kropp" [Live with your body]. Participants who were in need of further care after the intervention were offered continued treatment accordingly at the clinic.
If a participant chose to terminate the intervention, or deteriorated during the intervention to the point that other treatment was needed, further treatment was agreed upon in dialogue with the patient. If needed, further assessment and physical examination was conducted in accordance to the clinics standard procedures.
Data was collected at four times for all participants. At treatment start and end, and follow-up at 12 and 24 months after inclusion. At each time, the participants were prompted to fill in five different self-assessment forms.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Orebro County Counsil
-
Orebro, Orebro County Counsil, Sweden, 701 85
- Eriksbergsgarden, Orebro County Counsil
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosed with an eating disorder according to DSM-IV (APA, 1994)
- Enrolled as a patient at Eriksbergsgarden, a clinic in Sweden offering specialized care for patients with an eating disorder
- Attained a somewhat regular eating pattern consisting of at least three meals per day
Exclusion Criteria:
- Having physical or psychiatric complicating factors of such severity that these conditions needed to be addressed during the treatment period (12 weeks).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Treatment as usual
|
Treatment as usual contains different interventions available at the clinic, such as individual therapy, group therapy, or contact with a physician, dietician and/or physiotherapist.
|
|
EXPERIMENTAL: Acceptance and Commitment Therapy
|
ACT is provided in 12 weekly two hour long sessions in a group setting
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Eating disorder symptoms
Time Frame: 24 months follow up
|
Assessed through the Eating Disorder Examination-Questionnaire (EDE-Q).
The EDE-Q consists of 28 questions assessing eating disordered symptoms for the past 28 Days.
A global score is calculated based on 22 of the items, ranging from 0-6.
The 22 items can be divided into four subscales, assessing eating restraint, eating concern, shape concern and weight concern, also in the range of 0-6.
A higher score indicates more severe eating disordered symptoms.
|
24 months follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Mindful awareness
Time Frame: 24 month follow up
|
Assessed through the Mindful Attention Awareness Scale (MAAS).
The MAAS consists of 15 questions, ranging from 1 to 6.
A global score is calculated where higher scoring indicates more mindful awareness.
|
24 month follow up
|
|
Measure of body shape preoccupations.
Time Frame: 24 months
|
Assessed through the Body Shape Questionnaire (BSQ), a short Swedish version consisting of 8 questions.
A total score is calculated, ranging from 8 to 48, where higher scoring indicates more severe concerns.
|
24 months
|
|
Measurement of body checking
Time Frame: 24 months
|
Assessed through the Body Checking Questionnaire (BCQ).
The BCQ consist of 23 questions ranging from 1 to 5. A global score is calculated ranging from 23 to 115, where a higher scoring indicates more frequent use of behaviours related to a negative body image.
|
24 months
|
|
Measure changes in self-concept
Time Frame: 24 months
|
Assessed through the Self-Concept Questionnaire (SCQ).
The SCQ consists of 30 questions ranging from 0 to 7. A global score is calculated where higher scorings indicates a higher self-esteem.
|
24 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Differences in amount of healthcare received after treatment intervention
Time Frame: 24 months
|
Assess the amount of received healthcare at the eating disorder clinic in terms of amounts of sessions after the intervention endpoint, and at end of follow-up.
|
24 months
|
|
The participants opinions regarding the intervention
Time Frame: 24 months
|
After last follow up participants are asked to participate in a qualitative interview, with focus on what was helpful and not in the intervention, according to the participants own reflections
|
24 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Sanna Gustafsson, PhD, Psychiatric research centre, Orebro County Counsil
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2009/294
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Eating Disorder
-
University of Sao Paulo General HospitalActive, not recruitingBinge Eating DisorderBrazil
-
University of North Carolina, Chapel HillThe Hilda & Preston Davis Foundation; Global Foundation for Eating DisordersCompletedEating Disorder | Binge-eating DisorderUnited States
-
Sao Jose do Rio Preto Medical SchoolFundação de Amparo à Pesquisa do Estado de São PauloCompletedBinge-Eating Disorder | Eating Disorders | Eating Behavior | Eating Disorder | Binge Eating Disorder Associated With ObesityBrazil
-
ShireCompleted
-
Lindner Center of HOPEUniversity of CincinnatiCompleted
-
Axsome Therapeutics, Inc.Enrolling by invitationBinge-Eating DisorderUnited States
-
BioprojetCompleted
-
Axsome Therapeutics, Inc.RecruitingBinge-Eating DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedBinge-Eating DisorderUnited States
-
Nova Scotia Health AuthorityCompletedBinge-Eating Disorder | Eating DisorderCanada
Clinical Trials on Acceptance and Commitment Therapy
-
Anne Roche, MACompletedQuality of Life | AgingUnited States
-
Universidade Federal do ParanáActive, not recruitingObsessive-Compulsive DisorderBrazil
-
University of CoimbraUnknown
-
Texas Tech UniversityRecruitingGrief | Anxiety Disorder Generalized | Depression in AdultsUnited States
-
Ataturk UniversityNot yet recruitingChronic Mental DisordersTurkey
-
Universiti Sains MalaysiaRecruitingBreast Cancer FemaleMalaysia
-
University of CyprusNot yet recruitingDepression | Anxiety Disorders | Post Traumatic Stress Disorder
-
University of TromsoThe Royal Norwegian Ministry of HealthCompleted
-
University of NottinghamNottinghamshire Healthcare NHS Foundation Trust; Derbyshire Healthcare NHS...Completed
-
University of Alabama at BirminghamWithdrawn